Korean J Obstet Gynecol.  2006 Apr;49(4):866-873.

Clinicopathologic characteristics and prognostic factors in adenocarcinoma of the uterine cervix

Affiliations
  • 1Department of Obstetrics and Gynecology, Catholic University Medical College, Seoul, Korea. haenam_1@hanmail.net

Abstract


OBJECTIVE
To evaluate clinicopathologic characteristics and prognostic factors in adenocarcinoma of the uterine cervix.
METHODS
Medical records of patients with adenocarcinoma of the cervix who primarily underwent radical hysterectomy and pelvic lymphadenectomy (n=72) at A Hospital from August 1998 to July 2004 were retrospectively reviewed. Patients with stage IA1-IIB lesions were included in the study. Clinical and pathological data were reviewed and analyzed.
RESULTS
Mean age at presentation was 46.5 years. The mean follow-up time for surviving patients was 35 months. The overall survival rate was 91.7% and disease free survival rate was 88.9%. Using univariate analysis, stage, lymph-vascular space invasion (LVSI), parametrial invasion, pelvic lymph node invasion and depth of stromal invasion were significant for survival, whereas grade, age, endometrial invasion were not significant. But using multivariate analysis, only stage and pelvic lymph node invasion remained significant independent predictors for survival.
CONCLUSION
Our study demonstrates that survival rate is high for patients with early stage, after primary surgery. We found stage and pelvic lymph node invasion of significant prognostic value for survival in cervical adenocarcinoma.

Keyword

Adenocarcinoma; Cervix; Survival rate; Prognostic factors

MeSH Terms

Adenocarcinoma*
Cervix Uteri*
Disease-Free Survival
Female
Follow-Up Studies
Humans
Hysterectomy
Lymph Node Excision
Lymph Nodes
Medical Records
Multivariate Analysis
Retrospective Studies
Survival Rate
Full Text Links
  • KJOG
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr